Development and validation of an Onchocerca ochengi microfilarial hamster model for onchocerciasis drug screens

被引:0
作者
Glory Enjong Mbah
Rene Bilingwe Ayiseh
Fidelis Cho-Ngwa
机构
[1] Faculty of Science,Department of Biochemistry and Molecular Biology
[2] University of Buea,undefined
来源
BMC Infectious Diseases | / 16卷
关键词
Onchocerciasis; Hamsters; Drug screens; Microfilariae; Ivermectin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 139 条
[1]  
Fenwick A(2012)The global burden of neglected tropical diseases Public Health 126 233-6
[2]  
Coffeng LE(2014)African programme for onchocerciasis control 1995–2015: updated health impact estimates based on new disability weights PLoS Negl Trop Dis 8 e2759-91
[3]  
Stolk WA(2011)Ocular onchocerciasis: current management and future prospects Clin Ophthalmol 5 1479-6
[4]  
Zouré HGM(1998)Onchocerciasis Lancet 351 1341-40
[5]  
Veerman JL(1995)Interleukin 4 and T helper type 2 cells are required for development of experimental onchocercal keratitis (river blindness) J Exp Med 182 931-22
[6]  
Agblewonu KB(1997)Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Lancet 350 18-94
[7]  
Murdoch ME(2009) infection Parasit Vectors 2 7-93
[8]  
Babalola OE(2011)Onchocerciasis control: vision for the Future from a Ghanian perspective PLoS Negl Trop Dis 5 e998-51
[9]  
Burnham G(1988)Phenotypic evidence of emerging ivermectin resistance in J Helminthol 62 181-45
[10]  
Pearlman E(1982)Chemotherapy of Parasitology 85 283-90